Dynamics of racial disparities in all-cause mortality during the COVID-19 pandemic

被引:14
|
作者
Aschmanna, Helene E. [1 ]
Riley, Alicia R. [2 ]
Chen, Ruijia [1 ]
Chen, Yea-Hung [1 ]
Bibbins-Domingo, Kirsten [1 ]
Stokes, Andrew C. [3 ]
Glymour, M. Maria [1 ]
Kiang, Mathew V. [4 ]
机构
[1] Univ Calif San Francisco, Dept Epidemiol & Biostatist, San Francisco, CA 94158 USA
[2] Univ Calif, Dept Sociol, Santa Cruz, CA 95064 USA
[3] Boston Univ Sch Publ Hlth, Dept Global Hlth, Boston, MA 02118 USA
[4] Stanford Univ Sch Med, Dept Epidemiol & Populat Hlth, Stanford, CA 94304 USA
关键词
pandemic; racial disparities; all-cause mortality; COVID-19;
D O I
10.1073/pnas.2210941119
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
As research documenting disparate impacts of COVID-19 by race and ethnicity grows, little attention has been given to dynamics in mortality disparities during the pandemic and whether changes in disparities persist. We estimate age-standardized monthly allcause mortality in the United States from January 2018 through February 2022 for seven racial/ethnic populations. Using joinpoint regression, we quantify trends in race-specific rate ratios relative to non-Hispanic White mortality to examine the magnitude of pandemic-related shifts in mortality disparities. Prepandemic disparities were stable from January 2018 through February 2020. With the start of the pandemic, relative mortality disadvantages increased for American Indian or Alaska Native (AIAN), Native Hawaiian or other Pacific Islander (NHOPI), and Black individuals, and relative mortality advantages decreased for Asian and Hispanic groups. Rate ratios generally increased during COVID-19 surges, with different patterns in the summer 2021 and winter 2021/2022 surges, when disparities approached prepandemic levels for Asian and Black individuals. However, two populations below age 65 fared worse than White individuals during these surges. For AIAN people, the observed rate ratio reached 2.25 (95% CI = 2.14, 2.37) in October 2021 vs. a prepandemic mean of 1.74 (95% CI = 1.62, 1.86), and for NHOPI people, the observed rate ratio reached 2.12 (95% CI = 1.92, 2.33) in August 2021 vs. a prepandemic mean of 1.31 (95% CI = 1.13, 1.49). Our results highlight the dynamic nature of racial/ethnic disparities in mortality and raise alarm about the exacerbation of mortality inequities for Indigenous groups due to the pandemic.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Racial Disparities in Potentially Avoidable Hospitalizations During the COVID-19 Pandemic
    Leuchter, Richard K.
    Villa, Chad Wes A.
    Norris, Keith C.
    Sorensen, Andrea
    Vangala, Sitaram
    Sarkisian, Catherine A.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2021, 61 (02) : 235 - 239
  • [42] Racial Disparities in Neighborhood Arrest Rates during the COVID-19 Pandemic
    Jaquelyn L. Jahn
    Jessica T. Simes
    Tori L. Cowger
    Brigette A. Davis
    Journal of Urban Health, 2022, 99 : 67 - 76
  • [43] The unequal burden of the Covid-19 pandemic: Capturing racial/ethnic disparities in US cause-specific mortality
    Luck, Anneliese N.
    Preston, Samuel H.
    Elo, Irma T.
    Stokes, Andrew C.
    SSM-POPULATION HEALTH, 2022, 17
  • [44] RACIAL DISPARITIES IN POTENTIALLY AVOIDABLE HOSPITALIZATIONS DURING THE COVID-19 PANDEMIC
    Leuchter, Richard K.
    Villaflores, Chad W.
    Norris, Keith C.
    Sorensen, Andrea
    Vangala, Sitaram
    Sarkisian, Catherine
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S72 - S73
  • [45] Racial Disparities in Neighborhood Arrest Rates during the COVID-19 Pandemic
    Jahn, Jaquelyn L.
    Simes, Jessica T.
    Cowger, Tori L.
    Davis, Brigette A.
    JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE, 2022, 99 (01): : 67 - 76
  • [46] Racial and Ethnic Disparities in Cancer Care During the COVID-19 Pandemic
    Patel, Manali I.
    Ferguson, Jacqueline M.
    Castro, Eida
    Pereira-Estremera, Cristina D.
    Armaiz-Pena, Guillermo N.
    Duron, Ysabel
    Hlubocky, Fay
    Infantado, Analynn
    Nuqui, Bles
    Julian, Donna
    Nortey, Nii
    Steck, Alexandra
    Bondy, Melissa
    Maingi, Shail
    JAMA NETWORK OPEN, 2022, 5 (07) : E2222009
  • [47] Impact of Metabolic Acidosis on All-Cause Mortality in Patients With COVID-19
    Kim, Yaerim
    Kwon, Soie
    Lee, Jeonghwan
    Paek, Jin Hyuk
    Park, Woo Yeong
    Jin, Kyubok
    Han, Seungyeup
    Kim, Dong Ki
    Lee, Jung Pyo
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 332 - 333
  • [48] In COVID-19, tocilizumab reduces all-cause mortality at 28 d
    Fernando, Shannon M.
    Rochwerg, Bram
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (06) : JC63 - JC63
  • [49] Predictors of All-Cause Mortality in Heart Transplant Recipients With COVID-19
    De Sirkar, Sovik
    Yu, Mingxi
    CIRCULATION, 2021, 144
  • [50] COVID-19 hospitalisations and all-cause mortality by risk group in Finland
    Summanen, Milla
    Kosunen, Mikko
    Kainu, Ville
    Cansel, Anniina
    Niskanen, Severi
    Nurmi, Lalli
    Leskelae, Riikka-Leena
    Isomeri, Outi
    PLOS ONE, 2023, 18 (05):